Russell Frank Company’s Avadel Pharmaceuticals AVDL Stock Holding History

Russell Frank Company’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.88M	Buy	532,305 +110,058	+26%	+$1.09M	0.01%	1232
2015 Q4	$6.12M	Buy	422,247 +56,752	+16%	+$885K	0.01%	1175
2015 Q3	$5.96M	Sell	365,495 -36,174	-9%	-$797K	0.01%	1173
2015 Q2	$8.51M	Buy	401,669 +60,072	+18%	+$1.08M	0.01%	1102
2015 Q1	$6.14M	Buy	341,597 +212,854	+165%	+$3.33M	0.01%	1123
2014 Q4	$2.21M	Buy	+128,743	New	+$1.84M	﹤0.01%	1734

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Russell Frank Company's AVDL Position: Q1 2016 in Review

Russell Frank Company increased its Avadel Pharmaceuticals (AVDL) stake by 26% in Q1 2016, buying an estimated $1.09M and bringing the position to 532,305 shares worth $5.88M. The position accounts for 0.01% of the portfolio, ranked #1232.

Russell Frank Company first reported a position in AVDL in Q4 2014 and has held it in 6 quarters since. The position peaked at $8.51M in Q2 2015. 81 funds tracked by Wall St. Rank hold AVDL as of Q1 2016.

Russell Frank Company held 532,305 shares of Avadel Pharmaceuticals worth $5.88M as of Q1 2016.
Russell Frank Company bought 110,058 Avadel Pharmaceuticals shares in Q1 2016, an estimated $1.09M.
Avadel Pharmaceuticals made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1232 holding.
Russell Frank Company first reported a position in Avadel Pharmaceuticals in Q4 2014 and has held it in 6 quarters since.
Russell Frank Company's Avadel Pharmaceuticals position peaked at $8.51M in Q2 2015.
81 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.